Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 669 | 1,208 | 597 | 1,106 | 587 |
| Cost of Goods | 661 | 770 | 373 | 426 | 294 |
| Gross Profit | 8 | 439 | 224 | 680 | 293 |
| Operating Expenses | 2,828 | 4,221 | 2,757 | 2,835 | 3,257 |
| Operating Income | -2,159 | -3,012 | -2,160 | -1,728 | -2,670 |
| Interest Expense | 8 | 6 | 4 | 7 | 84 |
| Other Income | 21 | 8 | 7 | 56 | 100 |
| Pre-tax Income | -2,147 | -3,010 | -2,157 | -1,679 | -2,654 |
| Net Income Continuous | -2,147 | -3,010 | -2,157 | -1,679 | -2,654 |
| Net Income | $-2,147 | $-3,010 | $-2,157 | $-1,679 | $-2,654 |
| EPS Basic Total Ops | -0.23 | -0.18 | -0.24 | -0.20 | -1.14 |
| EPS Basic Continuous Ops | -0.23 | -0.31 | -0.24 | -0.19 | -0.38 |
| EPS Diluted Total Ops | -0.23 | -0.18 | -0.24 | -0.20 | -1.14 |
| EPS Diluted Continuous Ops | -0.23 | -0.31 | -0.24 | -0.19 | -0.38 |
| EBITDA(a) | $-1,926 | $-2,580 | $-1,831 | $-1,477 | $-2,358 |